Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Kurzrock, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 132 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kurzrock, R; Cortes, J; Thomas, DA; Jeha, S; Pilat, S; Talpaz, M
      Pilot study of low-dose interleukin-11 in patients with bone marrow failure

      JOURNAL OF CLINICAL ONCOLOGY
    2. Kurzrock, R; Bueso-Ramos, CE; Kantarjian, H; Freireich, E; Tucker, SL; Siciliano, M; Pilat, S; Talpaz, M
      BCR rearrangement-negative chronic myelogenous leukemia revisited

      JOURNAL OF CLINICAL ONCOLOGY
    3. Laurent, E; Talpaz, M; Kantarjian, H; Kurzrock, R
      The BCR gene and Philadelphia chromosome-positive leukemogenesis

      CANCER RESEARCH
    4. Kurzrock, R
      The role of cytokines in cancer-related fatigue

      CANCER
    5. Gisslinger, H; Kurzrock, R; Gisslinger, B; Jiang, SW; Li, SR; Virgolini, I; Woloszczuk, W; Andreeff, M; Talpaz, M
      Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor

      BLOOD
    6. Fayad, L; Keating, MJ; Reuben, JM; O'Brien, S; Lee, BN; Lerner, S; Kurzrock, R
      Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

      BLOOD
    7. Esmaeli, B; Ahmadi, A; Tang, R; Schiffman, J; Kurzrock, R
      Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    8. Nash, RA; Kurzrock, R; DiPersio, J; Vose, J; Linker, C; Maharaj, D; Nademanee, AP; Negrin, R; Nimer, S; Shulman, H; Ashby, M; Jones, D; Appelbaum, FR; Champlin, R
      A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    9. Talpaz, M; Qiu, X; Cheng, K; Cortes, JE; Kantarjian, H; Kurzrock, R
      Autoantibodies to Abl and Bcr proteins

      LEUKEMIA
    10. Laurent, E; Talpaz, M; Wetzler, M; Kurzrock, R
      Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins

      LEUKEMIA
    11. Cohen, PR; Kurzrock, R
      Sweet's syndrome: A neutrophilic dermatosis classically associated with acute onset and fever

      CLINICS IN DERMATOLOGY
    12. Kurzrock, R
      Pentostatin (Nipent) in T-cell lymphomas

      SEMINARS IN ONCOLOGY
    13. Giles, FJ; Keating, AR; Kurzrock, R; Talpaz, M
      A pilot study of recombinant human interleukin-4 therapy of myelofibrosis

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    14. Ravandi, F; Estrov, Z; Kurzrock, R; Breitmeyer, JB; Maschek, BJ; Talpaz, M
      A phase I study of recombinant interferon-beta in patients with advanced malignant disease

      CLINICAL CANCER RESEARCH
    15. Beaupre, DM; Kurzrock, R
      RAS and leukemia: From basic mechanisms to gene-directed therapy

      JOURNAL OF CLINICAL ONCOLOGY
    16. Kurzrock, R; Pilat, S; Duvic, M
      Pentostatin therapy of T-cell lymphomas with cutaneous manifestations

      JOURNAL OF CLINICAL ONCOLOGY
    17. Cohen, PR; Kurzrock, R
      2-Chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients

      AMERICAN JOURNAL OF DERMATOPATHOLOGY
    18. Diamandidou, E; Colome, M; Fayad, L; Duvic, M; Kurzrock, R
      Prognostic factor analysis in mycosis fungoides/Sezary syndrome

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    19. Beaupre, DM; Kurzrock, R
      RAS inhibitors in hematologic cancers: Biologic considerations and clinical applications

      INVESTIGATIONAL NEW DRUGS
    20. Faderl, S; Talpaz, M; Estrov, Z; O'Brien, S; Kurzrock, R; Kantarjian, HM
      Mechanisms of disease - The biology of chronic myeloid leukemia

      NEW ENGLAND JOURNAL OF MEDICINE
    21. Beaupre, DM; Talpaz, M; Marini, FC; Cristiano, RJ; Roth, JA; Estrov, Z; Albitar, M; Freedman, MH; Kurzrock, R
      Autocrine interleukin-1 beta production in leukemia: Evidence for the involvement of mutated RAS

      CANCER RESEARCH
    22. Faderl, S; Kurzrock, R; Estrov, Z
      Minimal residual disease in hematologic disorders

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    23. TALPAZ M; KURZROCK R; KANTARJIAN H
      THE CLINICAL IMPACT OF INTERFERON USAGE IN HEMATOLOGIC MALIGNANCIES

      European cytokine network
    24. FAYAD L; CABANILLAS F; TALPAZ M; MCLAUGHLIN P; KURZROCK R
      HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMA

      Leukemia & lymphoma
    25. FERRAJOLI A; TALPAZ M; KURZROCK R; HARRIS D; VAN Q; ESTEY EH; ESTROV Z
      THROMBOPOIETIN STIMULATES MYELODYSPLASTIC SYNDROME GRANULOCYTE-MACROPHAGE AND ERYTHROID PROGENITOR PROLIFERATION

      Leukemia & lymphoma
    26. CORTES J; KANTARJIAN H; OBRIEN S; KURZROCK R; KEATING M; TALPAZ M
      GM-CSF CAN IMPROVE THE CYTOGENETIC RESPONSE OBTAINED WITH INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

      Leukemia
    27. KURZROCK R; TALPAZ M; BERAN M; HARRIS D; ESTROV Z
      DNA IN-SITU HYBRIDIZATION OF INDIVIDUAL COLONIES TO DETERMINE LINEAGEDERIVATION IN LEUKEMIA

      Leukemia
    28. KURZROCK R; ESTROV Z; KANTARJIAN H; TALPAZ M
      CONVERSION OF INTERFERON-INDUCED, LONG-TERM CYTOGENETIC REMISSIONS INCHRONIC MYELOGENOUS LEUKEMIA TO POLYMERASE-CHAIN-REACTION NEGATIVITY

      Journal of clinical oncology
    29. ESTROV Z; TALPAZ M; KU S; HARRIS D; VAN Q; BERAN M; HIRSCHGINSBERG C; HUH Y; YEE G; KURZROCK R
      Z-138 - A NEW MATURE B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE FROM A PATIENT WITH TRANSFORMED CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia research
    30. KURZROCK R; ESTROV Z; KU S; LEONARD M; TALPAZ M
      INTERLEUKIN-1 INCREASES EXPRESSION OF THE LYT-10 (NF-KAPPA-B2) PROTOONCOGENE TRANSCRIPTION FACTOR IN RENAL-CELL CARCINOMA LINES

      The Journal of laboratory and clinical medicine
    31. KURZROCK R; GRATWOHL A; PAQUETTE R; WYRES M; OKAMOTO D; YOUNG N
      TRILINEAGE RESPONSES SEEN WITH STEM-CELL FACTOR (STEMGEN(R), SCF) ANDFILGRASTIM (G-CSF) TREATMENT IN APLASTIC-ANEMIA (AA) PATIENTS (PTS)

      British Journal of Haematology
    32. DIAMANDIDOU E; COLOMEGRIMMER M; FAYAD L; DUVIC M; KURZROCK R
      TRANSFORMATION OF MYCOSIS FUNGOIDES SEZARY-SYNDROME - CLINICAL CHARACTERISTICS AND PROGNOSIS/

      Blood
    33. KURZROCK R
      KI-LYMPHOMA AND INTERLEUKIN-6 - IN RESPONSE

      Annals of internal medicine
    34. KURZROCK R
      CYTOKINE DEREGULATION IN HEMATOLOGICAL MALIGNANCIES - CLINICAL AND BIOLOGICAL IMPLICATIONS

      Clinical cancer research
    35. KANTARJIAN HM; TALPAZ M; OBRIEN S; KURZROCK R; GUTTERMAN J; KEATING MJ; MCCREDIE KB; FREIREICH EJ
      CHRONIC MYELOGENOUS LEUKEMIA - PROGRESS AT THE M.-D.-ANDERSON-CANCER-CENTER OVER THE PAST 2 DECADES AND FUTURE-DIRECTIONS - FIRST FREIREICH,EMIL,J AWARD LECTURE

      Clinical cancer research
    36. CORTES J; KURZROCK R
      INTERLEUKIN-10 IN NON-HODGKINS-LYMPHOMA

      Leukemia & lymphoma
    37. GISSLINGER H; KURZROCK R; WETZLER M; TUCKER S; KANTARJIAN H; ROBERTSON B; TALPAZ M
      APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA - STUDIES OF STAGE-SPECIFICDIFFERENCES

      Leukemia & lymphoma
    38. TALPAZ M; KANTARJIAN HM; OBRIEN S; KURZROCK R
      THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE WITH INTERFERON-ALPHA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA

      Bailliere's clinical haematology
    39. SEYMOUR JF; TALPAZ M; KURZROCK R
      RESPONSE DURATION AND RECOVERY OF CD4(-ALPHA-RESISTANT HAIRY-CELL LEUKEMIA - 7-YEAR FOLLOW-UP() LYMPHOCYTES FOLLOWING DEOXYCOFORMYCIN IN INTERFERON)

      Leukemia
    40. KURZROCK R; STROM SS; ESTEY E; OBRIEN S; KEATING MJ; JIANG H; ADAMS T; TALPAZ M
      2ND CANCER RISK IN HAIRY-CELL LEUKEMIA - ANALYSIS OF 350 PATIENTS

      Journal of clinical oncology
    41. WETZLER M; KURZROCK R; ESTROV Z; BARONE S; ESTEY E; TALPAZ M
      SUPPRESSED FORMATION OF BONE-MARROW ADHERENT LAYERS DERIVED FROM ACUTE MYELOID-LEUKEMIA PATIENTS AFTER IN-VITRO EXPOSURE TO INTERLEUKIN-4

      Leukemia research
    42. COHEN PR; KURZROCK R
      MUCOCUTANEOUS PARANEOPLASTIC SYNDROMES

      Seminars in oncology
    43. COLOMEGRIMMER MI; DIAMANDIDOU E; FAUAD L; DUVIC M; KURZROCK R
      LARGE-CELL TRANSFORMATION IN MYCOSIS-FUNGOIDES - STUDY OF 26 CASES

      Laboratory investigation
    44. YOUNES A; AYOUB JP; SARRIS A; HAGEMEISTER F; NORTH L; PATE O; MCLAUGHLIN P; RODRIGUEZ MA; ROMAGUERA J; KURZROCK R; PRETI A; BACHIER C; SMITH T; CABANILLAS F
      PACLITAXEL ACTIVITY FOR THE TREATMENT OF NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A PHASE-II TRIAL

      British Journal of Haematology
    45. GISSLINGER H; GISSLINGER B; KURZROCK R; GRUMBECK E; TALPAZ M
      THE FAS-LIGAND IS NOT RESPONSIBLE FOR INTERFERON-INDUCED APOPTOSIS INDAUDI CELLS

      Blood
    46. DIAMANDIDOU E; COLOME M; FAYAD L; DUVIC M; KURZROCK R
      PROGNOSTIC FACTORS ANALYSIS IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME

      Blood
    47. FAYAD L; CABANILLAS F; TALPAZ M; MCLAUGHLIN P; KURZROCK R
      HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMAS

      Blood
    48. KURZROCK R; PAQUETTE R; GRATWOHL A; DONEY K; GABRILOVE J; PATTERSON M; RIVERA C; WYRES M; DAVIS MW; YOUNG N
      USE OF STEM-CELL FACTOR (STEGMEN(R), SCF) AND FILGRASTIM (G-CSF) IN APLASTIC-ANEMIA (AA) PATIENTS (PTS) WHO HAVE FAILED ATG ALG THERAPY/

      Blood
    49. NASH R; KURZROCK R; DIPERSIO J; NIMER S; VOSE J; MAHARAJ D; LINKER C; NADEMANEE A; NEGRIN R; ASHBY M; TREMBLAY T; JONES D; APPELBAUM F; CHAMPLIN R
      SAFETY AND ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS (PTS) WITH DELAYED PLATELET RECOVERY (DPR)

      Blood
    50. KURZROCK R; ESTROV Z; KANTARJIAN H; TALPAZ M
      CONVERSION OF INTERFERON-INDUCED, LONG-TERM CYTOGENETIC REMISSIONS INCHRONIC MYELOGENOUS LEUKEMIA TO PCR NEGATIVITY

      Blood
    51. FAYAD L; KURZROCK R; KEATING M; OBRIEN S; KANTARJIAN H; ANDREEFF M; PIERCE S; TALPAZ M; FREIREICH E; ESTEY E
      TREATMENT OF HAIRY-CELL LEUKEMIA (HCL) WITH 2-CDA - LONG-TERM FOLLOW-UP AT M.D.-ANDERSON-CANCER-CENTER

      Blood
    52. KURZROCK R; DIAMANDIDOU E; HA CS; COHEN PR
      MYCOSIS-FUNGOIDES AND TOTAL SKIN ELECTRON-BEAM RADIATION - RESPONSE

      Blood
    53. PRETI HA; CABANILLAS F; TALPAZ M; TUCKER SL; SEYMOUR JF; KURZROCK R
      PROGNOSTIC VALUE OF SERUM INTERLEUKIN-6 IN DIFFUSE LARGE-CELL LYMPHOMA

      Annals of internal medicine
    54. SEYMOUR JF; TALPAZ M; HAGEMEISTER FB; CABANILLAS F; KURZROCK R
      CLINICAL CORRELATES OF ELEVATED SERUM LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH UNTREATED HODGKINS-DISEASE

      The American journal of medicine
    55. COHEN PR; KURZROCK R
      TRANSIENT ACANTHOLYTIC DERMATOSIS AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE

      Acta dermato-venereologica
    56. ESTROV Z; TALPAZ M; KU S; HARRIS D; LAPUSHIN R; KOLLER CA; HIRSHGINSBERG C; HUH Y; YEE G; KURZROCK R
      MOLECULAR AND BIOLOGIC CHARACTERIZATION OF A NEWLY ESTABLISHED PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE (Z-33) WITH AN AUTOCRINE RESPONSE TO GM-CSF

      Leukemia
    57. DUVIC M; LEMAK NA; REDMAN JR; EIFEL PJ; TUCKER SL; CABANILLAS FF; KURZROCK R
      COMBINED-MODALITY THERAPY FOR CUTANEOUS T-CELL LYMPHOMA (VOL 34, PG 1022, 1996)

      Journal of the American Academy of Dermatology
    58. DUVIC M; LEMAK NA; REDMAN JR; EIFEL PJ; TUCKER SL; CABANILLAS FF; KURZROCK R
      COMBINED-MODALITY THERAPY FOR CUTANEOUS T-CELL LYMPHOMA

      Journal of the American Academy of Dermatology
    59. ESTROV Z; TALPAZ M; ZIPF TF; KANTARJIAN HM; KU S; OUSPENSKAIA MV; HIRSCHGINSBERG C; HUH Y; YEE G; KURZROCK R
      ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PHILADELPHIA (PH(1))-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA - STUDIES ON 2 NEWLYESTABLISHED PH(1)-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES (Z-119 AND Z-181)

      Journal of cellular physiology
    60. KELLOKUMPULEHTINEN P; TALPAZ M; HARRIS D; VAN Q; KURZROCK R; ESTROV Z
      LEUKEMIA-INHIBITORY FACTOR STIMULATES BREAST, KIDNEY AND PROSTATE-CANCER CELL-PROLIFERATION BY PARACRINE AND AUTOCRINE PATHWAYS

      International journal of cancer
    61. DIAMANDIDOU E; COHEN PR; KURZROCK R
      MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME

      Blood
    62. CHENG KD; KURZROCK R; ESTROV Z; LEVITZKI A; KANTARJIAN H; BERAN M; QIU XG; MCBRIDE M; CLARKSON B; TALPAZ M
      LEUKEMIA-CELL LINE INHIBITION OF CELL-PROLIFERATION, AUTOPHOSPHORYLATION, KINASE-ACTIVITY, AND INDUCTION OF APOPTOSIS BY TYRPHOSTIN AG1112 AND AG957

      Blood
    63. FERRAJOLI A; TALPAZ M; KURZROCK R; HARRIS D; VAN Q; ESTEY E; ESTROV Z
      THROMBOPOIETIN STIMULATES MYELODYSPLASTIC SYNDROME (MDS) GRANULOCYTE-MACROPHAGE AND ERYTHROID PROGENITOR PROLIFERATION

      Blood
    64. BEAUPRE DM; TALPAZ M; MARINI FC; CRISTIANO RJ; ROTH JA; ESTROV Z; FREEDMAN MH; KURZROCK R
      RAS IS REQUIRED FOR THE EXPRESSION OF IL-1-BETA IN 2 DIVERSE LEUKEMIC-CELL LINES

      Blood
    65. CHENG KD; KURZROCK R; KU S; DALSKI K; WANG J; TALPAZ M
      REDUCED FAK AND PAXILLIN PHOSPHORYLATION IN BCR-ABL TRANSFECTED 3T3 CELLS

      Blood
    66. ESTEY E; THALL PF; MEHTA K; ROSENBLUM M; BREWER T; SIMMONS V; CABANILLAS F; KURZROCK R; LOPEZBERESTEIN G
      ALTERATIONS IN TRETINOIN PHARMACOKINETICS FOLLOWING ADMINISTRATION OFLIPOSOMAL ALL-TRANS-RETINOIC ACID

      Blood
    67. COHEN PR; KURZROCK R
      MUCOCUTANEOUS PARANEOPLASTIC MANIFESTATIONS OF HEMATOLOGIC MALIGNANCIES - REPLY

      The American journal of medicine
    68. KURZROCK R; WETZLER M; ESTROV Z; TALPAZ M
      INTERLEUKIN-1 AND ITS INHIBITORS - A BIOLOGIC AND THERAPEUTIC MODEL FOR THE ROLE OF GROWTH-REGULATORY FACTORS IN LEUKEMIAS

      Cytokines and molecular therapy
    69. ESTROV Z; SAMAL B; LAPUSHIN R; KELLOKUMPULEHTINEN P; SAHIN AA; KURZROCK R; TALPAZ M; AGGARWAL BB
      LEUKEMIA INHIBITORY FACTOR BINDS TO HUMAN BREAST-CANCER CELLS AND STIMULATES THEIR PROLIFERATION

      Journal of interferon & cytokine research
    70. KELLOKUMPULEHTINEN P; TALPAZ M; KURZROCK R; HARRIS D; VAN Q; ESTROV Z
      LEUKEMIA INHIBITORY FACTOR (LIF) STIMULATES THE GROWTH OF HUMAN BREAST-CANCER CELLS

      European journal of cancer
    71. SEYMOUR JF; ESTEY EH; KEATING MJ; KURZROCK R
      RESPONSE TO INTERFERON-ALPHA IN PATIENTS WITH HAIRY-CELL LEUKEMIA RELAPSING AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE

      Leukemia
    72. ANDERSSON BS; COLLINS VP; KURZROCK R; LARKIN DW; CHILDS C; OST A; CORK A; TRUJILLO JM; FREIREICH EJ; SICILIANO MJ; DEISSEROTH AB
      KBM-7, A HUMAN MYELOID-LEUKEMIA CELL-LINE WITH DOUBLE PHILADELPHIA CHROMOSOMES LACKING NORMAL C-ABL AND BCR TRANSCRIPTS

      Leukemia
    73. COHEN PR; KURZROCK R
      UNTITLED

      Dermatologic clinics
    74. COHEN PR; KOHN SR; DAVIS DA; KURZROCK R
      MUIR-TORRE-SYNDROME

      Dermatologic clinics
    75. COHEN PR; KURZROCK R
      MISCELLANEOUS GENODERMATOSES - BECKWITH-WIEDEMANN SYNDROME, BIRT-HOGG-DUBE SYNDROME, FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME, HEREDITARY TYLOSIS, INCONTINENTIA PIGMENTI, AND SUPERNUMERARY NIPPLES

      Dermatologic clinics
    76. SEYMOUR JF; TALPAZ M; CABANILLAS F; WETZLER M; KURZROCK R
      SERUM INTERLEUKIN-4 LEVELS CORRELATE WITH PROGNOSIS IN DIFFUSE LARGE-CELL LYMPHOMA

      Journal of clinical oncology
    77. WETZLER M; KURZROCK R; ESTROV Z; ESTEY E; TALPAZ M
      CYTOKINE EXPRESSION IN ADHERENT LAYERS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA

      Leukemia research
    78. KURZROCK R; COHEN PR
      ERYTHEMA-GYRATUM-REPENS

      JAMA, the journal of the American Medical Association
    79. ESTROV Z; KURZROCK R; TALPAZ M
      CYTOKINES AND THEIR ANTAGONISTS IN MYELOID DISORDERS

      Seminars in hematology
    80. WETZLER M; TALPAZ M; YEE G; STASS SA; VANETTEN RA; ANDREEFF M; GOODACRE AM; KLEINE HD; MAHADEVIA RK; KURZROCK R
      CELL CYCLE-RELATED SHIFTS IN SUBCELLULAR-LOCALIZATION OF BCR - ASSOCIATION WITH MITOTIC CHROMOSOMES AND WITH HETEROCHROMATIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    81. KURZROCK R; COHEN PR
      CLASSIFICATION AND DIAGNOSIS OF ERYTHROMELALGIA

      International journal of dermatology
    82. WETZLER M; KURZROCK R; GOODACRE AM; MCLAUGHLIN P; KU S; TALPAZ M
      TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA TO LYMPHOMA OF TRUE HISTIOCYTIC TYPE

      Cancer
    83. KURZROCK R; KU S; TALPAZ M
      ABNORMALITIES IN THE PRAD1 (CYCLIN D1 BCL-1) ONCOGENE ARE FREQUENT INCERVICAL AND VULVAR SQUAMOUS-CELL CARCINOMA CELL-LINES/

      Cancer
    84. KURZROCK R
      PRESENCE OF EPSTEIN-BARR-VIRUS VIRAL INTERLEUKIN-10 IN THE SERUM OF PATIENTS WITH NONHUMAN IMMUNODEFICIENCY VIRUS-RELATED DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMAS - RESPONSE

      Blood
    85. SEYMOUR JF; TALPAZ M; KURZROCK R
      SPLENECTOMIZED PATIENTS HAVE MORE RAPID RECOVERY OF CD4- LONG-TERM FOLLOW-UP OF PATIENTS WITH HAIRY-CELL LEUKEMIA RESISTANT TO INTERFERON( LYMPHOCYTES FOLLOWING DEOXYCOFORMYCIN )

      Blood
    86. PRETI HA; TALPAZ M; CABANILLAS F; SEYMOUR J; TUCKER S; KURZROCK R; ANDERSON MD
      INTERLEUKIN-6 (IL-6) AS A PROGNOSTIC FACTOR IN DIFFUSE LARGE-CELL LYMPHOMA (DLCL) - A MULTIVARIATE-ANALYSIS

      Blood
    87. GISSLINGER H; KURZROCK R; JIANG S; ANDREEFF M; TALPAZ M
      FAS APO-1, ANOTHER INTERFERON-INDUCIBLE GENE

      Blood
    88. CORTES JE; TALPAZ M; CABANILLAS F; SEYMOUR JF; KURZROCK R
      SERUM LEVELS OF INTERLEUKIN-10 IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA - LACK OF CORRELATION WITH PROGNOSIS

      Blood
    89. KURZROCK R; COHEN PR
      CUTANEOUS PARANEOPLASTIC SYNDROMES IN SOLID TUMORS

      The American journal of medicine
    90. WETZLER M; KANTARJIAN H; KURZROCK R; TALPAZ M
      INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA

      The American journal of medicine
    91. KURZROCK R; COHEN PR
      MUCOCUTANEOUS PARANEOPLASTIC MANIFESTATIONS OF HEMATOLOGIC MALIGNANCIES

      The American journal of medicine
    92. ESTROV Z; TALPAZ M; MAVLIGIT G; PAZDUR R; HARRIS D; GREENBERG SM; KURZROCK R
      ELEVATED PLASMA THROMBOPOIETIC ACTIVITY IN PATIENTS WITH METASTATIC CANCER-RELATED THROMBOCYTOSIS

      The American journal of medicine
    93. FERRAJOLI A; TALPAZ M; ORDONEZ NG; STANLEY ER; HIRSCHGINSBERG C; ZIPF TF; WETZLER M; KURZROCK R; ESTROV Z
      INTERLEUKIN-4 ALTERS HUMAN BONE-MARROW STROMA AND MODULATES ITS INTERACTION WITH HEMATOPOIETIC PROGENITORS

      Stem cells
    94. TALPAZ M; ESTROV Z; KANTARJIAN H; KU S; FOTEH A; KURZROCK R
      PERSISTENCE OF DORMANT LEUKEMIC PROGENITORS DURING INTERFERON-INDUCEDREMISSION IN CHRONIC MYELOGENOUS LEUKEMIA - ANALYSIS BY POLYMERASE CHAIN-REACTION OF INDIVIDUAL COLONIES

      The Journal of clinical investigation
    95. WETZLER M; ESTROV Z; TALPAZ M; KIM KJ; ALPHONSO M; SRINIVASAN R; KURZROCK R
      LEUKEMIA INHIBITORY FACTOR IN LONG-TERM ADHERENT LAYER CULTURES - INCREASED LEVELS OF BIOACTIVE PROTEIN IN LEUKEMIA AND MODULATION BY IL-4,IL-1-BETA, AND TNF-ALPHA

      Cancer research
    96. WETZLER M; KURZROCK R; ESTROV Z; KANTARJIAN H; GISSLINGER H; UNDERBRINK MP; TALPAZ M
      ALTERED LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN CHRONIC MYELOGENOUS LEUKEMIA - CLINICAL AND PROGNOSTIC CORRELATES

      Blood
    97. WETZLER M; KURZROCK R; ESTROV Z; KANTARJIAN H; GISSLINGER H; UNDERBRINK MP; TALPAZ M
      ALTERED LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN CHRONIC MYELOGENOUS LEUKEMIA - CLINICAL AND PROGNOSTIC CORRELATES

      Blood
    98. OBRIEN S; KURZROCK R; DUVIC M; KANTARJIAN H; STASS S; ROBERTSON LE; ESTEY E; PIERCE S; KEATING MJ
      2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH T-CELL LYMPHOPROLIFERATIVE DISORDERS

      Blood
    99. TALPAZ M; PATTERSON M; KURZROCK R
      SEQUENTIAL ADMINISTRATION OF IL-3 AND GM-CSF IN BONE-MARROW FAILURE PATIENTS - A PHASE-I STUDY

      Blood
    100. WETZLER M; TALPAZ M; YEE G; STASS AS; VANETTEN RA; ANDREEFF M; GOODACRE AM; KLEINE HD; MAHADEVIA RK; KURZROCK R
      CELL CYCLE-RELATED SHIFTS IN SUBCELLULAR-LOCALIZATION OF BCR - ASSOCIATION WITH MITOTIC CHROMOSOMES AND WITH HETEROCHROMATIN

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 03:42:22